Allergan Inc (AGN)

AGN on New York Consolidated

165.60USD
10 Jul 2014
Price Change (% chg)

$0.40 (+0.24%)
Prev Close
$165.20
Open
$163.89
Day's High
$165.85
Day's Low
$163.06
Volume
1,592,621
Avg. Vol
4,488,736
52-wk High
$174.49
52-wk Low
$86.95

AGN

Chart for AGN

About

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye,... (more)

Overall

Beta: 0.76
Market Cap (Mil.): $49,035.42
Shares Outstanding (Mil.): 296.82
Dividend: 0.05
Yield (%): 0.12

Financials

  AGN Industry Sector
P/E (TTM): 39.68 35.07 35.49
EPS (TTM): 4.16 -- --
ROI: 14.27 18.94 18.21
ROE: 21.01 19.73 19.11
Search Stocks

Deals of the day- Mergers and acquisitions

(Adds Allergan, Fiat, Intesa Sanpaolo, Siemens, Omega Pharma, Mitsubishi, Sucafina, New Landsbanki, PSP Investment, African Bank Investments and Aareal)

07 Jul 2014

Pershing Square offers slate for Allergan board

July 7 - William Ackman's Pershing Square Capital Management proposed on Monday a slate of six directors for the board of Allergan Inc as the hedge fund presses forward with its $53 billion takeover bid with Valeant Pharmaceuticals International Inc for the Botox maker.

07 Jul 2014

Ackman's hedge fund Pershing Square surges 25 pct in first half

BOSTON, July 3 - Activist investor William Ackman's main fund climbed 25 percent during the first half of 2014, ranking the billionaire as one of this year's top hedge fund industry performers.

03 Jul 2014

Allergan readies defense as it fights Valeant

NEW YORK and LOS ANGELES - Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

01 Jul 2014

Investor Ackman hires Credit Suisse for Allergan bid: source

BOSTON - Activist investor William Ackman has hired Credit Suisse in his fight to have Valeant Pharmaceuticals acquire Botox maker Allergan Inc. , a person familiar with the matter said on Tuesday.

01 Jul 2014

Deals of the day- Mergers and acquisitions

(Adds Berkshire Partners, Nexter, Allergan, Club Mediterranee, and others; updates Kindred)

01 Jul 2014

Investor Ackman hires Credit Suisse for Allergan bid -source

BOSTON, July 1 - Activist investor William Ackman has hired Credit Suisse in his fight to have Valeant Pharmaceuticals acquire Botox maker Allergan Inc. , a person familiar with the matter said on Tuesday.

01 Jul 2014

UPDATE 1-Allergan readies defense as it fights Valeant for votes

NEW YORK and LOS ANGELES, July 1 - Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

01 Jul 2014

TIMELINE-Ackman and Valeant maneuver for Allergan

July 1 - Valeant Pharmaceuticals International Inc has teamed up with Pershing Square Capital Management, led by activist investor William Ackman, to make a run at Botox maker Allergan Inc. Here are the details of some of the most interesting steps along the way.

01 Jul 2014

DEALTALK-Allergan readies defense as it fights Valeant for votes

NEW YORK and LOS ANGELES, July 1 - Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.

01 Jul 2014

Competitors

  Price Change
Astellas Pharma Inc (4503.T) ¥1,339 -13.00
SANTEN PHARMACEUTICAL CO., LTD. (4536.T) ¥5,790 -20.00
Lupin Limited (LUPN.NS) Rs1,039.45 +1.05
Nestle SA (NESN.VX) CHF68.45 -0.35
Johnson & Johnson (JNJ.N) $105.80 -0.24
Pfizer Inc. (PFE.N) $30.00 -0.05
Novartis AG (NOVN.VX) CHF79.65 -0.35
High Tech Pharm Co.,Ltd. (106190.KQ) ₩14,300.00 -100.00
Merck & Co., Inc. (MRK.N) $58.58 +0.03
Roche Holding Ltd. (ROG.VX) CHF262.20 -3.30

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks